Latest news
Director gifts 6,050 TG Therapeutics (TGTX) shares to 501(c)(3) - Stock TitanStock Titan · Fri, 07 Aug 2026 21:01:37 GMTTG Therapeutics (TGTX) 2026 Q2 10-Q: Key Risks, Financials, and BRIUMVI Commercialization Update - MinichartMinichart · Thu, 06 Aug 2026 04:58:00 GMTTG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo! Finance CanadaYahoo! Finance Canada · Thu, 06 Aug 2026 03:48:44 GMTTG Therapeutics Earnings Call Signals BRIUMVI Surge - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 01:06:00 GMTTG Therapeutics 2026: Revenue $240.34M, EPS $0.05— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:02:08 GMTTG Therapeutics (NASDAQ: TGTX) grows 2026 revenue to $445 million - Stock TitanStock Titan · Wed, 05 Aug 2026 21:01:51 GMTEmpowered Funds LLC Increases Stake in TG Therapeutics, Inc. $TGTX - MarketBeatMarketBeat · Wed, 05 Aug 2026 08:36:17 GMTThree Noteworthy Biotechs Just Reported Earnings — And Only One Recovered - Investor's Business DailyInvestor's Business Daily · Mon, 03 Aug 2026 20:23:00 GMT